Proposed pharmaceutical regulations for skeletal muscle depolarization drugs.
Andresen
Brian D
BD
Grant
Patrick M
PM
McKillop
John
J
D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004349:Drug Packaging; D044707:Forensic Sciences / Q000379:methods; D006708:Homicide; D006761:Hospitals; D006801:Humans; D007554:Isotopes; D009467:Neuromuscular Depolarizing Agents / Q000032:analysis / Q000737:chemistry* / Q000506:poisoning; D003473:Neuromuscular Nondepolarizing Agents / Q000032:analysis / Q000737:chemistry* / Q000506:poisoning; D010197:Pancuronium / Q000032:analysis / Q000737:chemistry* / Q000506:poisoning; D013390:Succinylcholine / Q000032:analysis / Q000737:chemistry* / Q000506:poisoning
D007554:Isotopes; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine; D010197:Pancuronium